Your browser doesn't support javascript.
loading
Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.
Schweitzer, Morris; Makhoul, Sandra; Paliouras, Miltiadis; Beitel, Lenore K; Gottlieb, Bruce; Trifiro, Mark; Chowdhury, Shafinaz F; Zaman, Naif M; Wang, Edwin; Davis, Harry; Chalifour, Lorraine E.
Afiliação
  • Schweitzer M; Division of Endocrinology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada. Electronic address: morris.schweitzer@mcgill.ca.
  • Makhoul S; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada.
  • Paliouras M; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, H3A 1A3, QC, Canada.
  • Beitel LK; Division of Endocrinology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada.
  • Gottlieb B; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada.
  • Trifiro M; Division of Endocrinology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, H3A 1A3, QC, Canada.
  • Chowdhury SF; Biotechnology Research Institute - National Research Council, 6100 Royalmount, Montreal, H4P 2R2, QC, Canada.
  • Zaman NM; Biotechnology Research Institute - National Research Council, 6100 Royalmount, Montreal, H4P 2R2, QC, Canada.
  • Wang E; Biotechnology Research Institute - National Research Council, 6100 Royalmount, Montreal, H4P 2R2, QC, Canada.
  • Davis H; CVPath Institute Inc., 19 Firstfield Road, Gaithersburg, MD, 20878, USA.
  • Chalifour LE; Division of Endocrinology, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 chemin Cote Ste Catherine, Montreal, H3T 1E2, QC, Canada; Division of Experimental Medicine, Department of Medic
Atherosclerosis ; 246: 78-86, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26761771
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ezetimiba / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Proteínas de Membrana / Anticolesterolemiantes / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Atherosclerosis Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ezetimiba / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Proteínas de Membrana / Anticolesterolemiantes / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Atherosclerosis Ano de publicação: 2016 Tipo de documento: Article